FEMALE BACTERIA INFECTION.
BACTERIA
FOUND IN FEMALE GENITAL INFECTIONS
Streptococci
Many varieties of streptococci have been found in the pelvis, and
they have been
classified by two independent schemes. In one scheme, the
streptococci are
distinguished by their hemolytic properties on blood agar plates.
Aerobic streptococci
showing partial (or green) hemolysis are termed alpha (a)
streptococci, those showing
complete (or clear) hemolysis are termed beta (b) streptococci,
and those showing no
hemolysis are termed gamma (g) streptococci.
Group A Streptococci (Streptococcus
pyogenes)
Streptococcus pyogenes causes pharyngeal, cutaneous, puerperal, and postoperative
infections and necrotizing fasciitis. Sequelae of group A
streptococcal infections may
include rheumatic fever and acute glomerulonephritis. It is not
generally considered to
be a member of the normal vaginal flora, as it is isolated in less
than 1% of
asymptomatic women. Pelvic infection caused by group A
streptococci may produce a
characteristic clinical picture, with a high, early initial fever,
chills, prostration, and
diffuse tenderness. Historically, the group A b-hemolytic
streptococcus was the
organism responsible for fatal puerperal sepsis. On Gram stains,
one sees
Gram-positive cocci in chains. The microorganism remains
exquisitely sensitive to
penicillin, and erythromycin or a cephalosporin usually can be
substituted for treatment
of the penicillin-allergic patient. Clindamycin is an alternative
agent, as is vancomycin.
Group A streptococcal pelvic infections occur in both sporadic and
epidemic forms.
Epidemics usually are exogenous in origin, commonly resulting from
nasopharyngeal
carriage of the microorganism or from skin infections in hospital
staff members.
Occasionally, a mother may be the source.
Epidemics can be prevented by placing patients with group A
streptococcal infections in
strict isolation and by early antibiotic treatment of hospital
employees with group A
streptococcal infections. Employees with positive cultures should
be relieved of duty on
obstetric, neonatal, and postoperative wards until their cultures
become negative. When
epidemics have occurred, isolation and antibiotic therapy have not
always sufficed to
effect control. In some recent outbreaks, additional measures,
such as identifying and
treating all streptococcal carriers, canceling elective surgery,
and prophylactic treatment
of all patients and personnel, have been necessary.
Group B Streptococci (Streptococcus
agalactiae)
Before the 1960s, GBS were not recognized as frequent pathogens,
but they have now
become a major cause of sepsis among neonates and postpartum women.
Unlike group A streptococci, group B organisms are considered part of the
normal vaginal flora and can be recovered in about 20% of normal
pregnant women.
Isolation rates are enhanced by use of selective broth containing
nalidixic acid and
gentamicin. The clinical picture of GBS infection in puerperal
women closely resembles
that of group A infection. Epidemic GBS disease has not been
reported among mothers,
however. The neonate with GBS sepsis usually acquired the
microorganism from the
maternal genital tract. Even with appropriate therapy, early-onset
neonatal GBS
infection has a high fatality rate. In 1996, national guidelines
were established to prevent
GBS perinatal sepsis
Group D Streptococci
This group is composed of two subgroups: “group D enterococci” and
“group D not
enterococci.” The former, which includes Streptococcus
faecalis, Streptococcus
faecium, and other less common
species, occurs frequently. Although these organisms
cause endocarditis and urinary tract infection, their virulence in
genital infections has
been debatable. They are considerably less virulent than group A
or B streptococci, but
on occasion they have caused serious genital and abdominal
infections. Enterococci are
important pathogens, particularly in situations where
cephalosporin prophylaxis has
been used.
Staphylococci
The aerobic staphylococci include S. epidermidis,
Staphylococcus saprophyticus
(Micrococcus), and Staphylococcus
aureus. The first two do not produce a coagulase
enzyme (the “coag-negative” staphylococci), whereas S. aureus does
(“coag-positive”
staphylococci). Staphylococcus aureus is isolated from 5%
to 10% of genital tract
cultures. This organism has been recognized as a cause of
abdominal wound infections,
breast abscesses, and nursery outbreaks of infection. It has been
isolated from nearly
all patients with toxic shock syndrome. Most species of S.
aureus, whether isolated in
the community or in the hospital, elaborate penicillinase and are
resistant to penicillin
and ampicillin. Agents of choice for treatment of S. aureus infections
are the
penicillinase-resistant penicillins, such as cloxacillin,
dicloxacillin, methicillin, oxacillin,
and nafcillin. Resistance to these antibiotics by
methicillin-resistant S. aureus has
become a major nosocomial infection problem. Antibiotics for use
in S. aureus
infections in the penicillin-allergic patient are the
“first-generation” cephalosporins and
clindamycin. Vancomycin is the drug of choice for
methicillin-resistant S. aureus.
Staphylococcus saprophyticus has
been recognized recently as an important cause of
urinary tract infection. This organism is susceptible to a wide
range of antibiotics,
including penicillins, cephalosporins, and
trimethoprim-sulfamethoxazole (TMP-SMX).
Staphylococcus epidermidis is commonly
isolated from the vagina and skin, but rarely
causes infection. Conditions in which S. epidermidis is
recognized as a pathogen
include osteomyelitis, possibly late-onset neonatal sepsis, and
association with foreign
bodies and invasive lines.
Gram-Positive Bacilli
The Gram-positive bacilli are common organisms in the normal
vaginal flora.
Lactobacillus sp are the most
frequent component of the normal vaginal flora in women
of reproductive age. Although lactobacilli are generally
nonvirulent organisms, the
strains that produce hydrogen peroxide play a major role in
controlling the vaginal flora.
In unusual circumstances, the usually avirulent lactobacilli may
produce invasive
disease, such as bacteremia, which occurs in patients with
underlying conditions such
as cancer, recent surgery, and diabetes mellitus. Many of these
patients received prior
antibiotic therapy. When lactobacilli appear in cultures of the
urine, it almost certainly
represents a contamination.
Listeria monocytogenes is present
rarely in the vaginas of healthy women. Although the
predominant route for severe intrauterine infections due to this
organism during
pregnancy is transplacental secondary to bacteremia, on occasion L.
monocytogenes
ascends from the lower genital tract to cause intrauterine
infection.
Epidemics due to Listeria organisms have occurred from
contaminated dairy products.
Gram-Negative Bacilli
The Gram-negative bacilli include a large number of microorganisms
with highly variable
patterns of antimicrobial susceptibility. Many species have been
identified, but only a
few are commonly isolated from patients with pelvic infections.
Escherichia Coli
Escherichia coli is one of the most common members of this group isolated in
genital
tract and urine specimens. It is present in approximately 70% of
urinary tract infections.
Escherichia coli infections
usually are mild, but occasionally they may be fulminant, as it
is the microorganism most commonly identified in bacteremic
obstetric and gynecologic
patients. Escherichia coli frequently is recovered in mixed
infections of the pelvis, such
as amnionitis, endometritis, and posthysterectomy cellulitis. Its
susceptibility to
antibiotics varies from hospital to hospital and, probably, from
service to service.
Gentamicin, tobramycin, amikacin, and chloramphenicol usually are
effective against
more than 95% of E. coli isolates. Increasingly, E. coli
resistance to ampicillin has
emerged. In general, more than 40% of E. coli (including
community-acquired strains)
are resistant to ampicillin. The first-generation cephalosporin
antibiotics have remained
active against E. coli isolates in most hospitals, but the
newer cephalosporin agents
(second and third generation) and newer penicillins are more
active. The new quinolone
agents, such as ciprofloxacin and ofloxacin, are very active
against E. coli, as is
TMP-SMX.
Gardnerella vaginalis
Formerly known as Haemophilus vaginalis and Corynebacterium
vaginale, Gardnerella
vaginalis is found in vaginal
cultures of nearly all women with bacterial vaginosis, but it
also can be found in vaginal cultures of 40% to 60% of
asymptomatic women when a
selective medium is used. It has been reported to cause
endometritis and bacteremia. In
some institutions, G. vaginalis is the most common
Gram-negative aerobe recovered
from the endometrium and blood of patients with postpartum
endometritis. Gardnerella
vaginalis has been frequently
recovered from patients with pelvic inflammatory disease.
Rather than being a pathogen on its own, G. vaginalis probably
is involved by
association with other bacterial vaginosis organisms. In vitro testing
shows this
organism to be susceptible to ampicillin and tetracycline, but
these agents are of limited
value in curing bacterial vaginosis.
Klebsiella Species
Klebsiella sp are found in less than 10% of genital tract infections, but
they also cause
urinary tract infections and hospital-acquired pneumonia. Klebsiella
pneumoniae is the
most common member of this group recovered from genital tract and
urinary tract
infections. Klebsiella oxytocia is much less common. All
the cephalosporin antibiotics
are highly effective against Klebsiella organisms, as are
the aminoglycosides and
chloramphenicol. Ampicillin has little activity, but some of the
newer penicillins, such as
piperacillin and mezlocillin, have improved activity. Quinoline
agents are effective, as
are the new enzyme-blocking drugs, such as amoxicillin
(Augmentin), ticarcillin
(Timentin), ampicillin (Unasyn), and piperacillin (Zosyn).
Enterobacter Species
Although closely related to Klebsiella species, Enterobacter
species are encountered
much less frequently (less than 5% of genital infections). They
are more resistant to
antibiotics than are Klebsiella species. Until recently, Enterobacter
infections usually
required therapy with aminoglycoside antibiotics, but some of the
newer cephalosporins
and newer penicillins show good activity. The most common of this
group are
Enterobacter aerogenes and Enterobacter
cloacae.
Proteus Species
Proteus sp are isolated in 10% to 15% of genital tract infections and in a
similar
percentage of urinary tract infections. Proteus mirabilis, by
far the most commonly
isolated species in obstetric and gynecologic patients, is
susceptible to ampicillin and
the cephalosporins, as well as the aminoglycosides. Proteus
vulgaris occurs much less
commonly. Former Proteus species, Proteus morganii and
Proteus rettgeri, are now
classified as Morganella morganii and Providencia
rettgeri, respectively. These species
are resistant to ampicillin and the first-generation
cephalosporins, but they are sensitive
to the aminoglycosides and some of the newer penicillin and
cephalosporin antibiotics.
Pseudomonas Species
Opportunistic pathogens in severe, usually hospital-acquired,
infections, Pseudomonas
sp are found infrequently in infections in obstetrics and
gynecology, but Pseudomonas
colonization is seen commonly in patients receiving antibiotic
therapy. Antibiotic
susceptibility is good to gentamicin and usually better to
tobramycin and amikacin.
Activity of the newer penicillins and some of the newer
cephalosporins is good, and
combinations of antibiotics may produce higher cure rates in
serious infections.
Other Gram-Negative Bacilli
Other Gram-negative bacilli include microorganisms such as Serratia,
Citrobacter,
Acinetobacter, and Providencia
species, all of which show resistance to commonly used
antibiotics. Fortunately, these species are found rarely among
obstetric and gynecologic
patients, except in those who are debilitated or who are receiving
antibiotic,
immunosuppressive, or cytotoxic therapy.
Gram-Negative Cocci.
In pelvic infections, the only significant member of the
Gram-negative cocci is Neisseria
gonorrhoeae, which may produce an
asymptomatic colonization of the cervix, cervicitis,
or salpingitis. Disseminated infection with septicemia, arthritis,
and
dermatitis occurs not infrequently. Neisseria gonorrhoeae is
a common cause of
neonatal conjunctivitis and has been reported recently as an
unusual cause of
amnionitis and fetal scalp abscess. Penicillinase-producing
strains of N. gonorrhoeae
have become a major problem in the United States. In addition,
chromosomally
mediated resistance and tetracycline resistance have emerged in N.
gonorrhoeae.
Penicillin is no longer a recommended antibiotic. Cephalosporins
or quinolones are
preferred, usually in single-dose regimens, for uncomplicated
gonococcal infections.
CHANGES IN VAGINAL MICROFLORA
One should not conclude from this description of vaginal
microflora that it is a static
situation. Certainly, there are vast differences in flora between
different groups of
women and interesting shifts from time to time in the flora of one
particular woman.
Age
At birth, the vagina is sterile. Secondary to maternal estrogen
effect, lactobacilli growth
is enhanced for a short time. The estrogen effect is gone within
several weeks, and
lactobacilli disappear until the onset of puberty, when, under the
influence of
endogenous estrogen, the vaginal flora becomes dominated by
lactobacilli. It is
suggested that postmenopausal women have a decrease in Lactobacillus
colonization,
but that treatment with estrogens results in a higher rate of
recovery of lactobacilli and
probably of diphtheroids. Thus, there seems to be an important
interaction between
vaginal colonization and hormonal milieu. Changes associated with
aging have been
reported in other groups of bacteria, but the conclusions are less
uniform.
Sexual Activity
Sexual intercourse leads to changes in lower genital tract
microorganisms, mainly
sexually transmitted ones. In addition to introducing major
pathogens such as N.
gonorrhoeae, C. trachomatis, and
herpesvirus, intercourse leads to increases in genital
mycoplasmas.
Contraception
Use of oral contraceptives appears to have minimal effect on the
vaginal ecosystem. On
the other hand, use of intrauterine contraceptive devices
increases the number of
anaerobic bacteria in the cervix and augments the risk for bacterial
vaginosis, thus
increasing the risk for pelvic inflammatory disease.
Pregnancy And Delivery
A number of studies have suggested that there is a progressive
increase in colonization
by Lactobacillus organisms during pregnancy, but changes in
other bacterial groups are
not well established. After delivery, dramatic changes in vaginal
flora occur. There are
marked increases in anaerobic species by the third postpartum day.
Possible
predisposing features to anaerobic vaginal colonization in
postpartum women include
trauma, presence of lochia and suture material, examinations
during labor, and changes
in hormonal levels. By the sixth week postpartum, the vaginal
flora is restored to a
normal distribution.
Surgery
Major procedures, such as hysterectomy, lead to wide changes in
vaginal flora,
including decreases in lactobacilli and diphtheroids and increases
in aerobic and
anaerobic Gram-negative rods (predominantly E. coli and
various Bacteroides
[Prevotella]). In addition, most investigators have noted a
further shift when prophylactic
or therapeutic antibiotics are used. As expected, use of
antibiotics results in a decrease
in susceptible flora and a corresponding increase in resistant
organisms.
Homeostasis
Homeostatic mechanisms have been identified that function to
maintain the stability of
the normal vaginal flora. Production of hydrogen peroxide by
certain Lactobacillus
species appears to play a crucial role in maintaining the normal
vaginal ecosystem. In
addition, the low pH (acidity) of the normal vagina protects
against exogenous
organisms. Antimicrobial agents can disrupt the normal vaginal
ecosystem, especially if
they eliminate the hydrogen peroxide-producing lactobacilli
0 Comments